Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Aldosterone Blockade to Prevent Hypertension and Cardiorenal Damage in Subclinical Primary Aldosteronism

NCT07727252 is registered in ClinicalTrials.gov with Xinjiang Medical University as lead sponsor.

NCT NCT07727252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07727252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Aldosterone Blockade to Prevent Hypertension and Cardiorenal Damage in Subclinical Primary Aldosteronism
Lead sponsor
Xinjiang Medical University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 1, 2029
Enrollment
880 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

subclinical primary aldosteronism